SEC Filing | Loews Corporation

View:

As filed with the Securities and Exchange Commission on December 1, 2004
==============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13E-3
Transaction Statement under Section 13(e) of the Securities
Exchange Act of 1934*

BULOVA CORPORATION
(Name of the Issuer)

2004-LCBV Corporation
Loews Corporation
(Name of Persons Filing Statement)

Common Stock, Par Value $5.00 Per Share
(Title of Class of Securities)

120457 10 6
(CUSIP Number of Class of Securities)

Gary W. Garson
Loews Corporation
667 Madison Avenue
New York, New York 10021
212-521-2000

(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications on Behalf of Persons Filing Statement)

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THIS TRANSACTION, PASSED UPON THE
MERITS OR THE FAIRNESS OF THE TRANSACTION OR PASSED UPON THE ADEQUACY OR
ACCURACY OF THE INFORMATION CONTAINED IN THIS DOCUMENT. ANY REPRESENTATION TO
THE CONTRARY IS A CRIMINAL OFFENSE.

This statement is filed in connection with (check the appropriate box):

[ ] a. The filing of solicitation materials or an information statement
subject to Regulation 14A, Regulation 14C or Rule 13e-3(c) under the
Securities Exchange Act of 1934.
[ ] b. The filing of a registration statement under the Securities Act of
1933.
[ ] c. A tender offer.
[ X ] d. None of the above.

Check the following box if the soliciting materials or information
statement referred to in checking box (a) are preliminary copies. [ ]

Check the following box if this is a final amendment reporting the
results of the transaction. [ ]

Calculation of Filing Fee

Transaction Valuation(1) Amount of Filing Fee
$5,249,930 $665
(1) Calculated, for the purposes of determining the filing fee only, in
accordance with Rule 0-11(b)(1) under the Securities Exchange Act of 1934,
as amended. Determined by multiplying 149,998, the number of shares of
common stock of Bulova held by shareholders other than Loews, by $35.00,
the price to be paid per share.

[ ] Check the box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing with which the offsetting
fee was previously paid. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.

Amount Previously Paid: Filing Party:

- ----------------------

* This statement also constitutes Amendment No. 17 to the Statement on
Schedule 13D previously filed by Loews Corporation with respect to the common
stock of Bulova Corporation.

Form or Registration No.: Filing Date:
==============================================================================

SUMMARY

This summary and the remainder of this Transaction Statement on Schedule 13E-3
provide information describing the "going private" merger involving Bulova
Corporation, referred to as "Bulova," 2004-LCBV Corporation, referred to as
"Merger Sub," and Loews Corporation, referred to as "Loews." We sometimes
refer to Merger Sub and Loews together as the "Filing Persons" or "we" or
"us." This statement includes discussions of, among other things, how the
merger affects you, what your rights are with respect to the merger as a
shareholder of Bulova and our position on the fairness of the merger to you
and the other public shareholders of Bulova, who we refer to as Bulova's
"public shareholders."

OVERVIEW AND PURPOSE OF THE MERGER (SEE PAGE 2).

. Loews currently owns approximately 97% of Bulova's outstanding common
stock.

. Merger Sub was recently organized as a wholly owned subsidiary of Loews
to effect the merger with Bulova. Prior to effecting the merger, Loews
will contribute all of its shares of Bulova common stock to Merger Sub.

. Thereafter, Merger Sub will merge with and into Bulova, with Bulova as
the surviving corporation. As a result of the merger, Bulova's public
shareholders (other than those, if any, who object to the merger and
properly exercise their statutory dissenters' rights, which are discussed
below) will receive $35.00 in cash for each of their shares of Bulova
common stock, and Bulova will become a wholly owned subsidiary of Loews.

. The purpose of the merger is for Loews to acquire all of the shares of
Bulova common stock that it does not already own, thus making Bulova a
private company and enabling Bulova to save the costs associated with
being a public company. At the same time, the merger will provide a
source of liquidity to Bulova's public shareholders and enable them to
receive cash for their shares without having to pay brokerage
commissions.

. Because Loews currently owns more than 90% of the outstanding shares of
Bulova common stock and will contribute these shares to Merger Sub,
Merger Sub is permitted under New York law to effect the merger by action
of its board of directors, without any action on the part of the board of
directors or public shareholders of Bulova.

. We will pay Bulova's public shareholders for their shares of Bulova
common stock promptly after the completion of the merger. Instructions
for surrendering stock certificates for payment will be set forth in a
Notice of Merger and a Letter of Transmittal, which will be mailed to
each Bulova public shareholder promptly after the effective date of the
merger. You should not submit your stock certificates until after you
receive and review these documents.

. We expect that the merger will become effective on or about [ ], 2005,
which is twenty (20) days after the date on which we are mailing this
statement to Bulova's public shareholders (or as soon thereafter as
possible).

. The total amount of funds necessary to make the cash payments that
Bulova's public shareholders will be entitled to receive and to pay
related expenses is estimated to be approximately $5,350,000. All of such
funds will be provided by Loews out of its available cash.

OUR POSITION ON THE FAIRNESS OF THE MERGER (SEE PAGE 4).

We have concluded that the merger is both substantively and procedurally fair
to Bulova's public shareholders based primarily on the following factors:

. The $35.00 per share merger price represents a significant premium to the
recent and historical range of trading prices of Bulova's common stock in
the over-the-counter market, including an 18.6% premium over the average
trading price during the twelve months ended November 15, 2004 and an
18.6% premium over the share price on November 24, 2004, the last trading
day on which a trade was reported prior to the announcement of our intent
to effect the merger. We believe that these percentage premiums compare
favorably to the range of percentage premiums of other comparable "going
private" transactions.

. The trading market for Bulova's common stock is extremely illiquid, with
an average of less than 500 shares being traded each week during the
twelve months ended November 15, 2004 and no trades at all taking place
on more than 225 out of 259 trading days during that period. The merger
represents an opportunity for Bulova's public shareholders to realize
cash for their shares, at a premium price, which would otherwise be
extremely difficult or impossible, given such illiquidity.

. The $35.00 per share merger price implies an enterprise value of Bulova
for approximately $152.2 million, which reflects a multiple of 0.93 times
Bulova's revenue, 9.8 times Bulova's earnings before interest, taxes,
depreciation and amortization and a charge for environmental expenses
(referred to as "EBITDA"), and 17.3 times Bulova's net income, all for
the twelve months ended September 30, 2004, and 13.8 times Bulova's
estimated net income for the year ending December 31, 2005. We
determined enterprise value by multiplying the $35.00 per share merger
price by the number of shares of Bulova common stock outstanding and
adding net debt (which includes post-retirement liabilities less cash and
cash equivalents, including cash received by Bulova in October 2004 from
the sale of its Brooklyn, N.Y. warehouse, which in this case is a
negative number). We believe that these multiples compare favorably to
the range of multiples of other publicly traded companies of comparable
size in comparable industries.

. The merger consideration will be paid entirely in cash and is not subject
to any financing condition or deferral.

. Each Bulova public shareholder is entitled to exercise dissenters' rights
under New York law and to demand payment of the "fair value" for his or
her shares of Bulova common stock, as determined by a court in a
judicial proceeding.

CONSEQUENCES OF THE MERGER (SEE PAGE 3).

Completion of the merger will have the following consequences:

. Bulova will become a wholly owned subsidiary of Loews.

. Each share of Bulova common stock owned by a Bulova public shareholder
(other than those, if any, held by Bulova public shareholders who
properly exercise their dissenters' rights) will be converted into the
right to receive $35.00 in cash.

. Shares of Bulova common stock will no longer be publicly traded. In
addition, Bulova will no longer be subject to the costly reporting and
other requirements of the Securities Exchange Act of 1934, as amended,
including those recently instituted under the Sarbanes-Oxley Act of 2002,
and the requirements to file annual, quarterly and other reports with the
Securities and Exchange Commission.

. Only Loews will have the opportunity to participate in the future
earnings and growth, if any, of Bulova. Similarly, only Loews will face
the risk of any losses from Bulova's operations or any decline in value
of Bulova after the merger.

RIGHTS OF DISSENTING SHAREHOLDERS (SEE PAGE 9).

Any Bulova public shareholder who objects to the merger will have the right to
dissent from the merger and demand payment of the "fair value" of his or her
shares of Bulova common stock, as determined in a judicial appraisal
proceeding in accordance with Section 623 of the New York Business Corporation
Law. This value may be more or less than the $35.00 per share payable in the
merger. In order to perfect these rights, a dissenting shareholder must file a
written notice of election to dissent within 20 days after the date of mailing
of the Notice of Merger and must otherwise comply with the procedures set
forth in Section 623 of the New York Business Corporation Law. Those
procedures are summarized below under the caption of "Rights of Dissenting
Shareholders." Any failure by a dissenting shareholder to comply with the
procedures contained in Section 623 will result in an irrevocable loss of his
or her dissenters' rights. Any Bulova public shareholder who wishes to
exercise dissenters' rights is encouraged to seek advice from his or her legal
counsel.

FOR MORE INFORMATION (SEE PAGES 12 and 15).

Certain information regarding Bulova and Loews is set forth below under the
captions "Information About Bulova" and "Information About Us" and more
detailed information is available from their public filings with the
Securities and Exchange Commission.

iii

INTRODUCTION

This Transaction Statement on Schedule 13E-3 (this "Schedule 13E-3") is being
filed by (i) Loews Corporation, a Delaware corporation, and (ii) its wholly
owned subsidiary, 2004-LCBV Corporation, a New York corporation, pursuant to
Section 13(e) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and Rule 13e-3 thereunder. This Schedule 13E-3 provides
information relating to the "going private" merger of Merger Sub with and
into Bulova. This Schedule 13E-3 is first being mailed to Bulova's public
shareholders on or about [ ], 2004.

This Schedule 13E-3 and the documents incorporated by reference in this
Schedule 13E-3 include certain forward-looking statements within the meaning
of the federal securities laws. These forward-looking statements include
statements regarding our intent, belief or current expectations. Forward-
looking statements are inherently uncertain and subject to a variety of risks
that could cause actual results to differ materially from what we expect.
Given these risk factors, you should not place undue reliance on these
forward-looking statements. Any such forward-looking statements speak only as
of the date of this Schedule 13E-3 and we expressly disclaim any obligation or
undertaking to update any forward-looking statement to reflect any change in
expectations or any change in events, conditions or circumstances on which any
forward-looking statement is based.

DESCRIPTION OF THE MERGER

A total of 4,599,857 shares of Bulova's common stock, par value $5.00 per
share ("Bulova common stock"), are currently outstanding. Loews owns 4,449,859
shares, or approximately 97%, of such shares, and intends to transfer all of
them to Merger Sub prior to the effective date of a proposed short-form merger
of Merger Sub with and into Bulova pursuant to Section 905 of the New York
Business Corporation Law (the "NYBCL"). We expect that the merger will become
effective on or about [ ], 2005, which is twenty (20) days after the
date on which we are mailing this Schedule 13E-3 to Bulova's public
shareholders (or as soon thereafter as possible).

Upon the consummation of the merger, each outstanding share of Bulova common
stock will be canceled and, except for shares held by Merger Sub or any
shareholder of Bulova who properly exercises his or her statutory dissenters'
rights under the NYBCL, will be automatically converted into the right to
receive $35.00 per share in cash, without interest, upon surrender of the
certificate for such share to a paying agent who will be appointed by us to
make such payments. Instructions with regard to the surrender of stock
certificates for payment, together with a description of your dissenters'
rights, will be set forth in a Notice of Merger and a Letter of Transmittal,
which will be mailed to you promptly after the effective date of the merger.
You should not submit your stock certificates until you have received and
reviewed these documents.

Under the NYBCL, because Merger Sub will own more than 90% of the outstanding
shares of Bulova common stock immediately prior to the merger, Merger Sub will
have the power to effect the merger by action of its board of directors. No
approval is required or will be sought from the board of directors or public
shareholders of Bulova. Loews, as the sole shareholder of Merger

Sub, has approved the merger. Bulova will be the surviving corporation in the
merger and, following the merger, will be wholly owned by Loews.

PURPOSES, ALTERNATIVES, REASONS AND EFFECTS
OF THE MERGER

Purposes

The principal purpose of the merger is for Loews to acquire all of the shares
of Bulova common stock that it does not already own. This will enable Bulova
to eliminate the expenses, administrative burdens and potential liabilities
associated with being a public company. Given the very small number and
percentage of shares of Bulova common stock in public hands, we do not believe
the costs and burdens of maintaining Bulova's status as a public company are
justified. At the same time, the merger will provide a source of liquidity to
Bulova's public shareholders and an opportunity for them to obtain a return on
their investment, which, in the absence of such a transaction, might not be
realizable at any time in the foreseeable future, and to do so without having
to pay brokerage commissions.

Alternative Transaction Structures

We believe that effecting the transaction by way of a short-form merger
between Bulova and Merger Sub under New York law is the most efficient and
cost-effective way to accomplish the purposes described above. Alternative
transaction structures, such as a long-form merger or a tender offer, were not
considered since they would be unnecessarily time-consuming and costly,
without providing any advantages to Bulova's public shareholders, Loews or
Bulova.

Reasons for Taking Bulova Private

In determining whether to acquire the outstanding minority equity interest
held by Bulova's public shareholders and to effect the merger, we considered
the following factors to be the principal benefits of taking Bulova private:

. The cost savings resulting from Bulova ceasing to be a public company,
particularly those costs associated with Bulova having its annual
financial statements separately audited and with preparing and filing
separate quarterly, annual and other reports with the Securities and
Exchange Commission. These costs have increased significantly since the
passage in July 2002 of the Sarbanes-Oxley Act of 2002 and the extensive
rulemakings that followed by the Commission and the newly created Public
Company Accounting Oversight Board. We anticipate that the merger will
result in savings to Bulova of several hundred thousand dollars per year;
and

. The reduction in the amount of public information available to
competitors about Bulova's business and financial results that would
result from the termination of Bulova's obligations under the reporting
requirements of the Exchange Act.

We considered the alternative of leaving Bulova as a majority-owned, public
subsidiary. In our view, the lone advantage to us of this alternative would be
our ability to invest the cash to be paid to Bulova's public shareholders as
the merger price in other ways. We concluded that the advantages of taking
Bulova private significantly outweigh this limited advantage of leaving Bulova
as a majority-owned, public subsidiary, particularly in light of the recent
substantial increases in the costs and administrative burdens associated with
operating a public company following the adoption of the Sarbanes-Oxley Act.
Accordingly, we rejected this alternative.

We also considered the infrequency and extremely low volume of trading in
Bulova common stock and considered that the merger would result in immediate
and enhanced liquidity for Bulova's public shareholders.

Effects of the Merger

General. Upon completion of the merger, Loews will have complete control over
the conduct of Bulova's business and will have a 100% interest in the net
assets, the net book value and the net earnings of Bulova. In addition, Loews
will be the sole beneficiary of any future increases in the value of Bulova
and will bear the complete risk of any losses incurred in the operation of
Bulova and any decreases in the value of Bulova.

Shareholders other than Loews and Merger Sub. Upon completion of the merger,
Bulova's public shareholders will no longer have any interest in, and will not
be shareholders of, Bulova and therefore will not participate in Bulova's
future earnings and potential growth and will no longer bear the risk of any
losses incurred in the operation of Bulova and any decreases in the value of
Bulova. In addition, Bulova's public shareholders will not share in any
distribution of proceeds from any future sales of assets or businesses of
Bulova or its subsidiaries, none of which are contemplated at this time. All
of the other incidents of stock ownership of Bulova's public shareholders,
such as the rights to vote on certain corporate decisions, to elect directors
and to receive dividends and distributions upon the liquidation of Bulova, as
well as the benefit of potential increases in the value of their holdings in
Bulova based on any improvements in Bulova's future performance, will be
extinguished upon completion of the merger.

Upon completion of the merger, Bulova's public shareholders also will not bear
the risks of potential decreases in the value of their holdings in Bulova
resulting from any downturns in Bulova's future performance. Instead, Bulova's
public shareholders will have liquidity, in the form of the cash merger price,
in place of an ongoing equity interest in Bulova. In summary, if the merger
is completed, Bulova's public shareholders will have no ongoing rights as
shareholders of Bulova (other than the right to exercise dissenters' rights
with respect to the merger, as described below).

Bulova Common Stock. Once the merger is consummated, public trading of Bulova
common stock will cease and we intend to apply to deregister Bulova's common
stock under the Exchange Act. As a result, Bulova will no longer be required
to file reports with the Securities and Exchange Commission or otherwise be
subject to the federal securities laws applicable to public companies.

OUR POSITION AS TO THE FAIRNESS OF THE MERGER

Because we own substantially all of the outstanding Bulova common stock, we
may be deemed to be "affiliates" of Bulova within the meaning of Rule 12b-2
under the Exchange Act. Accordingly, the rules of the Securities and Exchange
Commission require us to express our view as to the substantive and procedural
fairness of the merger to you and Bulova's other public shareholders.

We believe that the merger is both substantively and procedurally fair to you
and Bulova's other public shareholders. As discussed in greater detail below,
with respect to substantive fairness, our belief is based on the following
factors:

. The merger represents an opportunity for Bulova's public shareholders to
realize cash for their shares, which might otherwise be extremely
difficult or impossible, given the illiquidity of the market for Bulova
common stock. Historically, trading in Bulova common stock has been
extremely light. As a result, any Bulova public shareholder who desires
to sell even a relatively small number of shares would likely find demand
for such shares to be very limited, and persistent attempts to sell such
shares could lead to a reduction in the price to be received for such
shares.

. The merger price of $35.00 per share of Bulova common stock compares
favorably with the range of prices at which the shares have traded
historically and in recent periods, including an 18.6% premium over the
average trading price during the twelve months ended November 15, 2004
and an 18.6% premium over the share price on November 24, 2004, the last
trading day on which a trade was reported prior to the announcement of
our intent to effect the merger. We believe that these percentage
premiums compare favorably to the range of percentage premiums of other
comparable "going private" transactions. We also do not believe that it
is realistic to expect that the market would sustain a price equal to or
in excess of $35.00, particularly if more than a very small number of
Bulova's public shareholders sought to sell their shares of Bulova common
stock.

. The $35.00 per share merger price implies an enterprise value for Bulova
of approximately $152.2 million, which reflects a multiple of 0.93 times
Bulova's revenue, 9.8 times Bulova's earnings before interest, taxes,
depreciation and amortization and a charge relating to environmental
expenses (referred to as "EBITDA") and 17.3 times Bulova's net income,
all for the twelve months ended September 30, 2004, and 13.8 times
Bulova's estimated net income for the year

ending December 31, 2005. We believe that these multiples compare
favorably to the range of multiples of other publicly traded companies of
comparable size in comparable industries.

. The merger consideration will be paid to Bulova's public shareholders
entirely in cash and is not subject to any financing condition or
deferral.

With respect to procedural fairness, we recognize that New York law allows us
to effect the merger by action of Merger Sub's board of directors, without any
action on the part of the board of directors or other shareholders of Bulova,
but provides Bulova's public shareholders who object to the merger with the
statutory right to have the "fair value" of their shares determined by a court
and paid to them by following the procedures outlined in Section 623 of the
NYBCL, which are described elsewhere in this Statement under the heading
"Rights of Dissenting Shareholders."

A determination of fair value ultimately depends on an analysis of what a
reasonable purchaser would pay for Bulova common stock. In order to make our
determination, we conducted various analyses which are described below. We
primarily considered the historical and recent trading prices for Bulova
common stock, our analyses of Bulova's enterprise value relative to comparable
companies, and the merger price premium relative to comparable "going private"
transactions.

. Market Price of Bulova Common Stock. As stated above, in considering the
fairness of the merger to Bulova's public shareholders, we considered the
trading activity in Bulova common stock, including a review of both
historical and recent reported market prices and trading volumes. The
most recent date on which a trade was reported prior to the date on which
our intent to effect the merger was first announced was November 24,
2004, and the last reported sale price on that date was $29.50 on trading
volume of 216 shares. The $35.00 merger price represents a premium of
18.6% over this last reported price. The average closing prices of Bulova
common stock, as reported by Nasdaq, during the three months, one year
and three years ended November 15, 2004 were $29.44, $29.50 and $27.15 on
average weekly trading volume of 209, 482 and 330 shares, respectively.
The $35.00 merger price represents a premium of 18.9%, 18.6% and 29.0%,
respectively, over these historical trading prices. See "Information
Concerning Bulova - Market for Bulova's Common Stock." Moreover, Bulova
common stock has never traded at or above $35.00 per share, other than on
a single day late in 2001 when a closing price of $37.00 was reported on
a volume of 2,000 shares. The closing price on the immediately prior day
on which any trading was reported was $20.00 on a volume of 200 shares,
and the closing prices on the subsequent two trading days were $30.00 and
$20.00 on volumes of 300 shares and 1,000 shares, respectively.
Therefore, we do not believe that this unexplained single day price
increase is meaningful and we did not consider it in determining or
evaluating the fairness of the merger price.

We believe that $35.00 represents a fair price when compared with recent
and historical reported trading prices. We recognize, however, that, due
to the very

small public float of Bulova common stock and the very low trading
volume, there are inherent limitations on the extent to which the market
can serve as a meaningful proxy for fair value. Nevertheless, we believe
that trading price levels over time are useful in providing an overall
analysis of the value of Bulova and Bulova common stock.

. Enterprise Value; Comparable Company Analysis. We conducted an analysis
of the enterprise value of Bulova and then compared the multiples
represented by the merger price to certain trading multiples of a group
of 15 companies, which we believed to be generally comparable to Bulova,
each of which is publicly traded, operates in the consumer products
industry (in the categories of apparel and accessories, appliances and
tools, and jewelry and silverware), and has a total market capitalization
of between $100 million and $500 million. We note that these comparable
companies do not represent the entire universe of potentially relevant
companies, and that none of the companies used in the analysis is
identical to Bulova. The companies included were Applica Incorporated,
Ashworth, Inc., Cutter and Buck Inc., Haggar Corp., Hampshire Group,
Limited, Hartmarx Corporation, Movado Group, Inc., National Presto
Industries, Inc., OshKosh B'Gosh, Inc., Perry Ellis International, Inc.,
Quaker Fabric Corp., Samsonite Corporation, St. John Knits Int'l, Inc.,
Superior Uniform Group and Water Pik Technologies.

By multiplying the per share merger price of $35.00 by the 4,599,857
shares of Bulova common stock outstanding and adding net debt (including
post-retirement liabilities, less cash and cash equivalents, including
cash received by Bulova in October 2004 from the sale of its Brooklyn,
N.Y. warehouse, which in this case is a negative number), we obtained an
enterprise value for Bulova of approximately $152.2 million. This value
is equivalent to 0.93 times Bulova's revenues, 9.8 times Bulova's EBITDA
and 17.3 times Bulova's net income, all for the twelve months ended
September 30, 2004, and 13.8 times Bulova's estimated net income for the
year ending December 31, 2005.

We then compared these multiples to the trading multiples of the
comparable companies, based on financial information obtained through
Yahoo Finance. As we did for Bulova, we determined enterprise value for
the comparable companies by calculating market capitalization (shares
outstanding multiplied by price per share), plus the company's debt
obligations, if any, less the company's cash, cash equivalents and short-
term investments. Our analysis indicated the following:

Enterprise Value as a Multiple of Share Price as a Multiple of
--------------------------------- ----------------------------
Last Twelve Last Twelve Last Twelve 2005
Months Months Months Estimated
Revenues EBITDA EPS EPS*
-------- ------ --- ---

Low 0.26x 4.46x 11.1x 8.3x
High 1.33x 14.3x 35.7x 22.4x
Median 0.69x 7.3x 14.6x 15.0x
Bulova 0.93x 9.8x 17.3x 13.8x

- --------------------------------
*not available for all comparable companies

We note that the multiples represented by the merger price were within
or above the range of the trading multiples of the comparable companies
and believe that the merger price multiples compare favorably to the
comparable companies. As noted above, none of the comparable companies
is identical or directly comparable to Bulova. Further, an analysis of
publicly-traded comparable companies is not mathematical; rather, it
involves complex consideration and judgments concerning differences in
financial and operating characteristics of the comparable companies and
other factors that could affect the public trading of the comparable
companies.

. Comparable Transaction Analysis. We also conducted a comparable
transaction analysis for the purpose of comparing the merger price to the
prices paid in other "going private" transactions.

There is limited public information available on "going private"
transactions effected through a short-form merger involving the
acquisition of 5% or less of the equity interest in a public company by
the majority shareholder. Consequently, we expanded our comparable
transaction analysis to include "going private" transactions involving
the acquisition of up to 10% of the total equity of a public company.

We reviewed the terms of 29 "going private" transactions that were
announced since 1995, each of which involved the acquisition of a
minority interest of 10% or less, where the price per share was greater
than $1.00 and the total value of the acquired shares was less than $50
million. We analyzed the merger price as a percentage premium to the
share price on the day prior to the announcement of each comparable
transaction. This analysis indicated that the percentage premium paid in
these transactions ranged from a high of 93.9% to a low of -4.6%, with a
median percentage premium of 14.8%. This compares to a premium of 18.6%
which the merger price represents over the last reported sales price per
share of

Bulova common stock on November 24, 2004, the last trading day on which a
trade was reported prior to the announcement of our intent to effect the
merger.

Based on the range of premiums paid in those transactions which we deemed
generally comparable to the merger, we believe that the $35.00 merger
price is fair to Bulova's public shareholders.

. Net Book Value per Share of Bulova Common Stock. We determined that the
net book value per share of Bulova common stock was $34.85 as of
September 30, 2004, based on Bulova's reported shareholders' equity of
$160.3 million, and a total of 4,599,857 shares of Bulova common stock
outstanding as of such date. We believe that, while net book value per
share is not a dispositive, or even a primary, factor in the valuation of
Bulova common stock, it is a useful metric in an overall analysis of such
value. We believe that the $35.00 merger price compares favorably to
Bulova's net book value.

. Discounted Cash Flow Analysis. We did not conduct a discounted cash flow
analysis since neither we nor Bulova prepare any projections of Bulova's
future cash flows beyond the current year. Projected future cash flows
or earnings forecasts are a key variable in performing such an analysis.

. Liquidation Analysis. We did not conduct a liquidation analysis since we
intend to continue to operate Bulova as a going concern and not to
liquidate the company.

We considered all of the foregoing factors and related analyses as a whole to
support our belief that the merger is substantively and procedurally fair to
Bulova's public shareholders. We also considered the following four
additional factors, which could have negatively impacted our determination:

. Following the merger, Bulova's public shareholders will cease to
participate in the future earnings or growth, if any, of Bulova or
benefit from an increase, if any, in the value of Bulova common stock.

. In determining and evaluating the fairness of the merger price, our
interests conflict with and are adverse to the interests of Bulova's
public shareholders.

. The merger is being effected as a "short-form" merger under New York law
and consequently does not require approval by the board of directors or
public shareholders of Bulova.

. Because no action is required or is being taken by the board of directors
of Bulova, the board did not establish a special committee of
disinterested or independent directors to represent the interests of
Bulova's public shareholders and did not engage an independent adviser to
assist in evaluating the fairness of the transaction, including the
merger price, to Bulova's public shareholders.

After considering these additional four factors, we concluded that none of
these factors, alone or in the aggregate, is significant enough to outweigh
the factors and analyses that we took into account to support our belief that
the merger is substantively and procedurally fair to Bulova's public
shareholders.

In view of the variety of factors considered in connection with making a
determination as to the fairness of the merger to Bulova's public
shareholders, and the complexity of these matters, we did not find it
practicable, nor did we attempt, except as described above, to quantify, rank
or otherwise assign relative weights to the specific factors we considered.
Moreover, we did not undertake to make any specific determination or assign
any particular weight to any single factor, but have conducted an overall
analysis of the factors described above.

We did not consider any factors, other than as stated above, regarding the
fairness of the merger to Bulova's public shareholders, as it is our view that
the factors we considered provided a reasonable basis to form our belief. We
did not consider the purchase prices paid by Loews for its shares of Bulova
common stock in prior years to be material to our conclusion regarding the
fairness of the merger and Loews has not acquired any shares of Bulova common
stock in more than ten years. In addition, from time to time over the years
since Loews acquired its Bulova shares, Loews and/or Bulova have engaged in
discussions with unrelated third parties that expressed interest in purchasing
Bulova. None of these discussions proceeded past a preliminary stage and we
did not give significant consideration to these discussions in fixing the
merger price. In the most recent case, after conducting preliminary due
diligence, a potential strategic buyer verbally indicated a range of values it
might be willing to pay for Bulova that was well below any price that might
have been acceptable to Loews and that was well below the $35.00 per share
merger price to be paid by Loews to Bulova's public shareholders.

REPORTS, OPINIONS, APPRAISALS AND NEGOTIATIONS

We did not engage any third parties to perform any financial analysis of, or
prepare any reports, opinions or appraisals concerning, the merger or the
value of Bulova or Bulova common stock and, accordingly, we did not receive
any report, opinion or appraisal from an outside party relating to the
fairness of the merger price being offered to Bulova's public shareholders or
the fairness of the merger to us or to Bulova's public shareholders. The
analyses described above were performed by internal personnel at Loews.

RIGHTS OF DISSENTING SHAREHOLDERS

Bulova public shareholders who object to the merger have certain rights under
New York law. These rights, commonly called "appraisal" or "dissenters'"
rights, entitle Bulova's public shareholders who follow required procedures to
ask a court to determine the fair value of their shares and require us to pay
that amount to such shareholders. The amount so determined may be more or
less than the merger price payable in the merger. Appraisal rights will not be
available unless and until the merger is consummated.

New York law provides that dissenters' rights are the exclusive remedy
available to shareholders who object to the merger, unless the transaction is
unlawful or fraudulent.

The following is a brief summary of the statutory procedures you must follow
in order to perfect your dissenters' rights under New York law. This summary
is not intended to be complete and is qualified in its entirety by reference
to Sections 623 and 910 of the NYBCL, the texts of which are set forth in
Exhibit (f) to this Schedule 13E-3. If you are considering pursuing your
dissenters' rights, we would advise you to consult legal counsel since the
failure to comply strictly with these provisions will result in a loss of your
dissenters' rights.

Dissenters' rights cannot be exercised at this time. The information set forth
below is for informational purposes only with respect to alternatives
available to you if the merger is consummated. Following the merger, you will
receive additional information concerning your dissenters' rights and the
procedures to be followed to exercise those rights.

Promptly after the merger, a Notice of Merger and a Letter of Transmittal will
be mailed to you for use in surrendering your shares for the cash payment you
are entitled to receive as a result of the merger. The Notice of Merger will
also explain your dissenters' rights and the procedures to be followed in
order to exercise them. If you elect to dissent from the merger, then within
20 days after the Notice of Merger is mailed to you, you must file a written
notice of your election to dissent with Bulova stating (i) your name and
residence address, (ii) the number of shares as to which you dissent (which
must be all of your shares of Bulova common stock) and (iii) a demand for
payment of the fair value of your shares. If you complete and return the
Letter of Transmittal and submit your share certificates for payment of the
merger price, you will be deemed to have irrevocably waived your dissenters'
rights.

At the time of filing a notice of election to dissent, or within one month
thereafter, you must submit the certificates representing your Bulova shares
to Bulova or its transfer agent for notation on the certificates of your
election to dissent, after which the certificates will be returned to you.
Failure to submit the certificates for such notation may result in the loss of
your dissenters' rights.

Within 15 days after the expiration of the period during which you may file a
notice of election to dissent, we and Bulova are required to make a written
offer to each Bulova public shareholder who has properly filed such a notice
to pay for his or her shares at a specified price which we consider to be the
fair value of those shares. We will make such an offer, but we do not intend
to offer to pay more than $35.00 per share. Such offer will be accompanied by
a statement setting forth the aggregate number of shares with respect to which
notices of election to dissent have been received and the aggregate number of
holders of such shares. Such offer will also be accompanied by (a) advance
payment to each dissenting shareholder who has submitted his or her
certificates for notation thereon of the election to dissent of an amount
equal to 80% of the amount of such offer or (b) as to each dissenting
shareholder who has not yet submitted his or her certificates, a statement
that we will make advance payment to him or her of such amount promptly upon
submission of his or her certificates. Acceptance of such advance payment by
a dissenting shareholder will not constitute a waiver of his or her
dissenters' rights.

If we fail to make the offer within such 15-day period, or if the offer is
made but a dissenting shareholder does not agree to it within 30 days after it
is made, we are required to institute a

special proceeding in the New York State Supreme Court, New York County, to
determine the rights of dissenting shareholders and to fix the fair value of
their shares of Bulova common stock. If we do not institute such a proceeding
within 20 days after the expiration of the 30-day period, any dissenting
shareholder may, within 30 days after such 20-day period, institute a
proceeding for the same purpose. We do not intend to institute an appraisal
proceeding. Therefore unless such a proceeding is instituted within such 30-
day period by a dissenting shareholder all shareholders who filed a notice of
election to dissent will lose their dissenters' rights (unless the court, for
good cause shown, otherwise directs). All dissenting shareholders, other than
those who agreed with us as to the price to be paid for their shares, will be
made parties to the appraisal proceeding. The court will determine whether
each dissenting shareholder is entitled to receive payment for his or her
shares, and will then determine the fair value of the shares of Bulova common
stock as of the close of business on the day prior to the date the merger was
authorized. In fixing the fair value of the shares, the court will consider
the nature of the transaction giving rise to Bulova's public shareholders'
right to dissent and its effects on Bulova and Bulova's public shareholders,
the concepts and methods then customary in the relevant securities and
financial markets for determining the fair value of shares of a corporation
engaging in a similar transaction under comparable circumstances and all other
relevant factors. Within 60 days after the completion of the proceeding, we
will pay to each dissenting shareholder the amount found to be due him or her,
with interest thereon at such rate as the court finds to be equitable, upon
surrender to us by such Bulova public shareholder of the certificates
representing his or her Bulova shares. If the court finds that any dissenting
shareholder's refusal to accept our offer was arbitrary, vexatious or
otherwise not in good faith, no interest shall be allowed to him or her.

The parties to the appraisal proceeding will bear their own costs and
expenses, including the fees and expenses of their counsel and of any experts
employed by them, except that the court, in its discretion and under certain
conditions, may assess all or any part of the costs, expenses and fees
incurred by dissenting shareholders against us or may assess all or any part
of the costs, expenses and fees incurred by us against any dissenting
shareholders, including any dissenting shareholders who have withdrawn their
notices of election, who the court finds were arbitrary, vexatious or
otherwise not acting in good faith in refusing any offer of payment we may
have made.

Any shareholder who files a notice of election to dissent will not have any
rights as a shareholder of Bulova after the merger, other than the right to be
paid the fair value of his or her shares under Section 623 of the NYBCL. Any
notice of election to dissent may be withdrawn by a dissenting shareholder at
any time within 60 days after the effective time of the merger (or, if we fail
to make a timely offer to pay such Bulova public shareholder the fair value of
his or her shares as provided above, at any time within 60 days after the date
such offer is made) or thereafter with our written consent. Any dissenting
shareholder who withdraws his or her notice of election to dissent or
otherwise loses his or her dissenters' rights will thereupon have the right to
receive the $35.00 per share merger price in cash for each of his or her
shares.

CERTAIN FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER

The following is a general summary of the material U.S. federal income tax
consequences of the merger to beneficial owners of shares of Bulova common
stock. This summary is based upon the provisions of the Internal Revenue Code
of 1986, as amended (the "Code"), applicable Treasury Regulations thereunder,
judicial decisions and current administrative rulings as in effect on the date
of this Schedule 13E-3. The discussion does not address all aspects of U.S.
federal income taxation that may be relevant to particular taxpayers in light
of their personal circumstances or to taxpayers subject to special treatment
under the Code (for example, financial institutions, regulated investment
companies, grantor trusts, insurance companies, tax-exempt organizations,
brokers, dealers or traders in securities or foreign currencies, persons
holding shares of Bulova common stock as part of a position in a "straddle" or
as part of a "hedging," "conversion" or "integrated" transaction for U.S.
federal income tax purposes, and persons that have a "functional currency"
other than the U.S. dollar). In addition, this summary does not address any
aspect of foreign, state, local or other tax laws, or any U.S. tax laws (such
as estate or gift tax) other than U.S. federal income tax laws.

Your receipt of cash pursuant to the merger or pursuant to the exercise of
dissenters' rights will be a taxable transaction for U.S. federal income tax
purposes. In general, you will recognize gain or loss for U.S. federal income
tax purposes equal to the difference between the amount of cash you receive
for your shares of Bulova common stock and your adjusted tax basis in your
shares. Such gain or loss will be capital gain or loss if you hold your Bulova
common stock as a capital asset, and generally will be long-term capital gain
or loss if, at the effective date of the merger, you have held your shares for
more than one year.

The cash payments made to you pursuant to the merger or pursuant to the
exercise of dissenters' rights will be subject to backup U.S. federal income
tax withholding, unless you provide the paying agent named in the Notice of
Merger and Letter of Transmittal that you will receive following the merger,
with your tax identification number (social security number or employer
identification number) and certify that such number is correct, or unless an
exemption from backup withholding applies.

You are urged to consult your tax advisor as to the specific tax consequences
of the merger to you, including the application of state, local, foreign and
other tax laws.

INFORMATION ABOUT BULOVA

Bulova is a New York corporation engaged in the business of selling and
distributing watches and clocks. The principal executive offices of Bulova are
located at One Bulova Avenue, Woodside, New York 11377-7874, and its telephone
number at that address is 718-204-3300.

Market for Bulova's Common Stock

The shares of Bulova common stock are traded in the over-the-counter ("OTC")
market and prices are posted on the "OTC Bulletin Board" under the symbol
"BULV."

The following table sets forth, for the periods indicated, the high and low
closing sale prices for Bulova's common stock in the OTC market, as reported
by Nasdaq.

High Low
---- ---

2004
First Quarter $30.50 $28.00
Second Quarter 31.00 29.25
Third Quarter 30.75 28.50
Fourth Quarter
(through 11/15/04) 30.00 29.75

2003
First Quarter $25.30 $25.00
Second Quarter 27.50 24.25
Third Quarter 28.40 27.00
Fourth Quarter 29.50 28.00

2002
First Quarter $26.00 $24.00
Second Quarter 26.50 25.00
Third Quarter 27.00 25.15
Fourth Quarter 27.00 25.00

On November 24, 2004, the last trading day on which a trade was reported prior
to the date on which our intent to effect the merger was first announced, the
closing sale price was $29.50. On [ ], 200[4], the last trading day on
which a trade was reported prior to the printing of this Schedule 13E-3, the
closing sale price was $[ ]. You are urged to obtain a current market
quotation for your shares of Bulova common stock.

Dividends

Bulova has not declared or paid any dividends on its common stock in more than
25 years.

Financial Information

The audited consolidated financial statements of Bulova as of and for the
years ended December 31, 2003 and 2002 are incorporated herein by reference to
Item 8 of Bulova's Annual Report on Form 10-K for its fiscal year ended
December 31, 2003 (the "Form 10-K Report"). The unaudited consolidated
financial statements of Bulova as of and for the three and nine months ended
September 30, 2004 and 2003 are incorporated herein by reference to Item 1 of
Bulova's Quarterly Report on Form 10-Q for the quarter ended September 30,
2004 (the "Form 10-Q Report"). The Form 10-K Report and the Form 10-Q Report
are referred to as the "Bulova Reports."

Bulova's book value per share of common stock as of September 30, 2004 was
$34.85. Bulova's ratio of earnings to fixed charges was 95.6x and 187.3x for
the years ended December 31, 2003 and 2002, respectively, and was 10.7x and
66.0x for the nine months ended September 30, 2004 and 2003, respectively.

Set forth below is certain selected consolidated financial information with
respect to Bulova and its subsidiaries excerpted or derived by us from the
audited consolidated financial statements of Bulova contained in the Form 10-K
Report and the unaudited financial statements of Bulova contained in the Form
10-Q Report. More comprehensive financial information is included in the
Bulova Reports and in other documents filed by Bulova with the Securities and
Exchange Commission, and the following financial information is qualified in
its entirety by reference to the Bulova Reports and other documents and all of
the financial information (including any related notes) contained therein or
incorporated therein by reference.

SUMMARY FINANCIAL INFORMATION
BULOVA CORPORATION
SUMMARY CONSOLIDATED FINANCIAL INFORMATION

(In thousands, except per share data) Nine Nine
Year Year Months Months
Ended Ended Ended Ended
12/31/2003 12/31/2002 9/30/2004 9/30/2003
--------------------------------------------------

Net sales $ 164,358 $ 164,538 $ 110,264 $ 111,361
Gross profit 86,318 86,649 56,441 58,834
Net income 12,148 12,268 895 6,685

Net income per common share $ 2.64 $ 2.67 $ 0.19 $ 1.45
Weighted average number of shares outstanding 4,599 4,599 4,599 4,599

September 30, December 31,
2004 2003 2002
------------------------------------------

Current assets $ 183,905 $ 188,374 $ 182,746
Non-current assets 31,410 32,160 33,149
Current liabilities 30,901 35,740 42,678
Non-current liabilities 24,112 24,723 29,789

Other Information

Bulova files annual, quarterly and current reports with the Securities and
Exchange Commission. You may read and copy any reports that Bulova files with
the Commission at the Commission's Public Reference Room located at 450 Fifth
Street, N.W., Washington, D.C. 20549. You may also receive copies of these
documents upon payment of a duplicating fee by writing to the Commission's
Public Reference Room. Please call the Commission at 1-800-SEC-0330 for
further information on the Public Reference Room in Washington, D.C. and other
locations. Bulova's filings with the Commission are also available to the
public from commercial document retrieval services and at the Commission's
website (www.sec.gov).

INFORMATION ABOUT US

Merger Sub

Merger Sub is a newly organized New York corporation which was formed for the
sole purpose of effecting the merger. It otherwise has no business
activities. The principal business address of Merger Sub, which also serves
as its principal office, is 667 Madison Avenue, New York, New York 10021, and
its telephone number at that address is 212-521-2000.

The name, business address, position with Merger Sub, principal occupation,
five-year employment history and citizenship of each of the directors and
executive officers of Merger Sub are set forth on Schedule I hereto. During
the last five years, neither Merger Sub nor any of the persons listed in
Schedule I has been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors). During the last five years, neither
Merger Sub nor any of the persons listed in Schedule I was a party to any
civil proceeding of a judicial or administrative body of competent
jurisdiction as a result of which any of such persons was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
activities subject to, federal or state securities laws or finding any
violation of such laws.

Loews Corporation

Loews is a Delaware corporation which operates as a holding company. Its
subsidiaries are engaged in property and casualty insurance, the production
and sale of cigarettes, the operation of hotels, the operation of offshore oil
and gas drilling rigs, the operation of an interstate natural gas transmission
pipeline system, and the distribution and sale of watches and clocks. The
principal business address of Loews, which also serves as its principal
office, is 667 Madison Avenue, New York, New York 10021, and its telephone
number at that address is 212-521-2000.

Loews owns 100% of the capital stock of Merger Sub and 4,449,859 shares of
Bulova common stock, substantially all of which it purchased in 1979 in a
privately negotiated purchase and a cash tender offer for all outstanding
shares. As noted above, Loews plans to contribute these shares to Merger Sub
prior to the effective date of the merger.

The name, business address, position with Loews, principal occupation, five-
year employment history and citizenship of the directors, executive officers
and other persons who may be deemed to be control persons of Loews are set
forth on Schedule I hereto. During the last five years,

neither Loews nor any of the persons listed in Schedule I has been convicted
in a criminal proceeding (excluding traffic violations or similar
misdemeanors). During the last five years, neither Loews nor any of the
persons listed in Schedule I was a party to any civil proceeding of a judicial
or administrative body of competent jurisdiction as a result of which any of
such persons was or is subject to a judgment, decree or final order enjoining
future violations of, or prohibiting activities subject to, federal or state
securities laws or finding any violation of such laws.

OUR PLANS AND PROPOSALS FOR BULOVA

We currently expect that, following the merger, the business and operations of
Bulova will be conducted by Bulova substantially as they are currently being
conducted. Loews intends to evaluate the business and operations of Bulova on
an ongoing basis with a view to maximizing its potential, and Loews will take
such actions as it deems appropriate under the circumstances and market
conditions then existing. Loews intends to cause Bulova to apply to terminate
the registration of Bulova common stock under Section 12(g)(4) of the Exchange
Act following the merger, which would result in the suspension of Bulova's
duty to file reports pursuant to the Exchange Act.

We do not currently have any commitment or agreement and are not currently
negotiating for the sale of any of Bulova's businesses. Additionally, we do
not currently contemplate any material change in the composition of Bulova's
current management.

Except as otherwise described in this Schedule 13E-3, Bulova has not, and we
have not, as of the date of this Schedule 13E-3, approved any specific plans
or proposals for:

. any extraordinary corporate transaction involving Bulova after the
completion of the merger;

. any sale or transfer of a material amount of assets currently held by
Bulova after the completion of the merger;

. any change in the board of directors or management of Bulova; or

. any material change in Bulova's dividend policy, indebtedness,
capitalization, corporate structure or business.

FEES AND EXPENSES; FINANCING OF THE MERGER

The total amount of funds necessary to make the cash payments that Bulova's
public shareholders will be entitled to receive as a result of the merger and
to pay related expenses is estimated to be approximately $5,350,000. All of
such funds will be provided by Loews out of its available cash.

The paying agent that will be appointed to make the cash payments payable
pursuant to the merger will receive reasonable and customary compensation for
its services and will be reimbursed for certain reasonable out-of-pocket
expenses and will be indemnified against certain

liabilities and expenses in connection with the merger, including certain
liabilities under U.S. federal securities laws.

We will not pay any fees or commissions to any broker or dealer in connection
with the merger. Brokers, dealers, commercial banks and trust companies will,
upon request, be reimbursed by Bulova for customary mailing and handling
expenses incurred by them in forwarding materials to their customers.

The following is an estimate of fees and expenses to be incurred by us in
connection with the merger:

Printing and mailing $35,000

Commission Filing Fee $ 665

Paying Agent $10,000

Legal Fees $50,000

Miscellaneous $ 4,335

TRANSACTION STATEMENT

ITEM 1. SUMMARY TERM SHEET

See the section above captioned "Summary."

ITEM 2. SUBJECT COMPANY INFORMATION

(a) NAME AND ADDRESS. The name of the company is Bulova Corporation.
See the section above captioned "Information about Bulova."

(b) SECURITIES. See the section above captioned "Description of the
Merger."

(d) DIVIDENDS. See the section above captioned "Information about
Bulova."

(e) PRIOR PUBLIC OFFERINGS. Neither of the Filing Persons has made an
underwritten public offering of Bulova's securities during the past
three years.

(f) PRIOR STOCK PURCHASES. Neither of the Filing Persons has purchased
any securities of Bulova during the past two years.

ITEM 3. IDENTITY AND BACKGROUND OF FILING PERSONS

(a) NAME AND ADDRESS. See the section above captioned "Information about
Us."

(b) BUSINESS AND BACKGROUND OF ENTITIES. See the section above captioned
"Information about Us."

(c) BUSINESS AND BACKGROUND OF NATURAL PERSONS. See the section above
captioned "Information about Us" and Schedule I hereto.

ITEM 4. TERMS OF THE TRANSACTION

(a) MATERIAL TERMS. See the section above captioned "Description of the
Merger."

(c) DIFFERENT TERMS. Shareholders of Bulova will be treated as described
in the section above captioned "Description of the Merger."

(d) APPRAISAL RIGHTS. See the section above captioned "Rights of
Dissenting Shareholders."

(e) PROVISIONS FOR UNAFFILIATED SECURITY HOLDERS. See the section above
captioned "Description of the Merger."

(f) ELIGIBILITY FOR LISTING OR TRADING. Not applicable.

ITEM 5. PAST CONTACTS, TRANSACTIONS, NEGOTIATIONS AND AGREEMENTS

(a) TRANSACTIONS. As a 97% owned subsidiary of Loews, Bulova and Loews
are parties to various agreements and arrangements, including the
following:

. A tax allocation agreement with respect to the filing by Loews of
consolidated federal income tax returns which include Bulova and its
subsidiaries, under which Bulova will (i) be paid by Loews the amount, if
any, by which Loews' consolidated federal income tax is reduced by virtue
of the inclusion of Bulova and its subsidiaries in Loews' consolidated
federal income tax return or (ii) pay to Loews an amount, if any, equal
to the federal income tax which would have been payable by Bulova if
Bulova and its subsidiaries had filed a separate consolidated return.
This agreement may be canceled by Bulova or Loews upon thirty days
written notice. Pursuant to this agreement, Bulova made estimated
payments to Loews amounting to $4,207,000 for the year ended December 31,
2003 and has accrued or paid $1,775,000 for the nine months ended
September 30, 2004.

. A services agreement pursuant to which Loews provides to Bulova various
administrative services, including among other things, data processing,
purchasing, accounts payable, printing, tax return preparation, insurance
and cash management services, and Bulova provides Loews with warehousing
services. Pursuant to this agreement, each party reimburses the other in
an amount not to exceed the allocated costs of the services provided.
Bulova paid Loews $3,000,000 for services provided during 2003 and has
accrued or paid approximately $2,250,000 for services provided during
the first nine months of 2004. In addition, Bulova has reimbursed Loews
approximately $872,000 for salaries and related employee benefits
expenses of employees of Loews on loan to Bulova for the year ended 2003
and has accrued or paid approximately $574,000 for the nine months ended
September 30, 2004.

. A credit agreement which provides for unsecured loans to be made by Loews
to Bulova from time to time, in principal amounts aggregating up to
$50,000,000. In September of 2003, Bulova borrowed $8,000,000, which was
repaid in December 2003. Prior to this borrowing, Bulova had not utilized
this credit facility since 1995. The interest rate for amounts
outstanding under this credit agreement is a fixed rate equal to the Six-
Month London Interbank Offered Rate in effect on the date Bulova requests
the loan, plus 250 basis points (2.5%). This credit agreement has been
periodically extended and currently expires on December 31, 2005.
Interest expense related to the Credit Agreement was $59,000 for the year
ended December 31, 2003. No interest has accrued for the nine months
ended September 30, 2004.

. Coverage under blanket insurance policies obtained by Loews, primarily
relating to property and casualty and general liability insurance, which
cover properties

and facilities of Loews and certain of its subsidiaries, including
Bulova. Bulova reimbursed Loews approximately $668,000 for premiums paid
for the year ended December 31, 2003 and has accrued or paid
approximately $675,500 for premiums paid for the nine months ended
September 30, 2004.

. Certain employee health and life insurance benefits provided by an
insurance subsidiary of CNA Financial Corporation, a 91% owned subsidiary
of Loews. Premiums and fees for such insurance amounted to approximately
$127,000 for the year ended December 31, 2003. On December 31, 2003, CNA
completed the sale of the majority of its Group Benefits business to
Hartford Financial Services Group, Inc., representing the line of
business Bulova had utilized in the past for certain employee health and
life insurance benefits.

. Information concerning the compensation paid by Loews to Messrs. Preston
R. Tisch and Andrew H. Tisch, both of whom are executive officers and/or
directors of Bulova (in addition to being executive officers and/or
directors of Loews), in their capacities as executive officers of Loews
in each of the last two years is set forth in Loews's proxy statements
for its 2003 and 2004 annual meetings, which are incorporated herein by
reference. Copies of Loews's proxy statements and other filings may be
obtained from the offices of the Securities and Exchange Commission in
the manner set forth with respect to Bulova's filings in the section
above captioned "Information About Bulova."

(b) SIGNIFICANT CORPORATE EVENTS. Except as described elsewhere in this
statement, there have been no negotiations, transactions or material
contacts that occurred during the past two years between (i) either of
the Filing Persons (including subsidiaries of the Filing Persons) or, to
the best knowledge of either of the Filing Persons, any of the persons
listed on Schedule I hereto and (ii) Bulova or its affiliates concerning
any merger, consolidation, acquisition, tender offer for or other
acquisition of any class of Bulova's securities, election of Bulova's
directors or sale or other transfer of a material amount of assets of
Bulova.

(c) NEGOTIATIONS OR CONTACTS. Except as described elsewhere in this
statement, there have been no negotiations or material contacts that
occurred during the past two years concerning the matters referred to in
paragraph (b) of this Item between (i) any affiliates of Bulova or (ii)
Bulova or any of its affiliates and any person not affiliated with Bulova
who would have a direct interest in such matters.

(e) AGREEMENTS INVOLVING THE SUBJECT COMPANY'S SECURITIES. There are no
agreements, arrangements or understandings, whether or not legally
enforceable, between either of the Filing Persons or, to the best
knowledge of either of the Filing Persons, any of the persons listed on
Schedule I hereto and any other person with respect to any securities of
Bulova.

ITEM 6. PURPOSES OF THE TRANSACTION AND PLANS OR PROPOSALS

(b) USE OF SECURITIES ACQUIRED. The shares of Bulova common stock
acquired in the merger from Bulova's public shareholders will be
canceled.

ITEM 7. PURPOSES, ALTERNATIVES, REASONS AND EFFECTS OF THE MERGER

See the sections above captioned "Purposes, Alternatives, Reasons and Effects
of the Merger" and "Certain Federal Income Tax Consequences of the Merger."

ITEM 8. FAIRNESS OF THE TRANSACTION

See the section above captioned "Our Position as to the Fairness of the
Merger."

ITEM 9. REPORTS, OPINIONS, APPRAISALS AND NEGOTIATIONS

See the section above captioned "Reports, Opinions, Appraisals and
Negotiations."

ITEM 10. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

(a) SOURCE OF FUNDS. See the section above captioned "Fees and Expenses;
Financing of the Merger."

(b) CONDITIONS. There are no conditions to the merger.

(d) BORROWED FUNDS. Not applicable.

ITEM 11. INTEREST IN SECURITIES OF THE SUBJECT COMPANY

(a) SECURITIES OWNERSHIP. On the effective date, immediately prior to
the merger, Merger Sub is expected to be the owner of 4,449,859
shares of Bulova common stock, representing approximately 97% of the
outstanding shares of Bulova common stock. Because Loews owns 100% of
the equity interest in Merger Sub, Loews may also be deemed to be the
beneficial owner of these shares. Details regarding the ownership of
Bulova common stock, if any, by the persons named on Schedule I to
this Schedule 13E-3 are set forth on such schedule.

(b) SECURITIES TRANSACTIONS. Loews will contribute 4,459,859 shares of
Bulova common stock to Merger Sub prior to the effective date of the
merger. There were no transactions in shares of Bulova common stock
effected during the past 60 days by the Filing Persons or, to the
best knowledge of the Filing Persons,

by the directors, executive officers, affiliates or subsidiaries of
either of the Filing Persons.

ITEM 12. THE SOLICITATION OR RECOMMENDATION

Not applicable.

ITEM 13. FINANCIAL STATEMENTS

See the section above captioned "Information about Bulova."

ITEM 14. PERSONS/ASSETS, RETAINED, EMPLOYED, COMPENSATED OR USED

(a) SOLICITATIONS OR RECOMMENDATIONS. There are no persons or classes of
persons who are directly or indirectly employed, retained, or to be
compensated for making solicitations or recommendations in connection
with the merger.

(b) EMPLOYEES AND CORPORATE ASSETS. Employees of Bulova may perform
ministerial acts in connection with the merger. No assets of Bulova
will be used in connection with the merger, including to fund the
merger consideration.

ITEM 15. ADDITIONAL INFORMATION

None.

ITEM 16. EXHIBITS

EXHIBIT NUMBER DESCRIPTION

(a) Letter from Loews to Bulova Shareholders.
(b) None.
(c) None.
(d) None.
(f) New York Business Corporation Law Sections
623 and 910.
(g) None.

SIGNATURES

After due inquiry and to the best of his knowledge and belief, each of the
undersigned certifies that the information set forth in this Statement is
true, complete and correct.

Dated: December 1, 2004

LOEWS CORPORATION

By: /s/ Gary W. Garson
Name: Gary W. Garson
Title: Senior Vice President

2004 - LCBV CORPORATION

By: /s/ Gary W. Garson
Name: Gary W. Garson
Title: Senior Vice President

Schedule I

INFORMATION CONCERNING THE DIRECTORS AND EXECUTIVE OFFICERS
OF 2004 - LCBV CORPORATION AND LOEWS CORPORATION

The following tables set forth (i) name and business address, (ii) current
principal occupation or employment and the name, principal business and
address of any corporation or other organization in which such employment is
conducted and (iii) material occupations, positions, offices or employment
during the past five years of each of the directors and executive officers of
2004 - LCBV Corporation and Loews Corporation. Except as set forth below,
each of such person's business address is 667 Madison Avenue, New York, NY
10021. All of the persons listed below are citizens of the United States.
None of such persons owns any securities of Bulova.

DIRECTORS AND EXECUTIVE OFFICERS
OF 2004-LCBV CORPORATION

Name and Current Principal Five Year Employment
Business Address Employment History

James S. Tisch See Below See Below
President and Director

Peter W. Keegan See Below See Below
Senior Vice President and Director

Gary W. Garson See Below See Below
Senior Vice President and Director

DIRECTORS AND EXECUTIVE OFFICERS
OF LOEWS CORPORATION

Name and Business Address Current Principal Employment Five Year Employment History

Joseph L. Bower Donald K. David Professor of Professor Bower has been in his
Harvard Business School Business Administration, current position for more than
Morgan 467, Soldiers Field Harvard University the past five years.
Boston, MA 02163 (Loews Director)

John Brademas President Emeritus, Dr. Brademas has been in his
New York University New York University current position for more than
King Juan Carlos I of Spain Ctr. (Loews Director) the past five years.
53 Washington Sq. So., 3rd Flr.
New York, NY 10012

Charles M. Diker Managing Partner, Mr. Diker has been in his
Diker Management Diker Management LLC current position for more
745 Fifth Avenue, Suite 1409 (Loews Director) than the past five years.
New York, NY 10153

Paul J. Fribourg Chairman of the Board and Mr. Fribourg has been in his
ContiGroup Companies, Inc. Chief Executive Officer, current position for more than
277 Park Avenue, 50th Flr. ContiGroup Companies the past five years.
New York, NY 10172 (Loews Director)

Gary W. Garson Senior Vice President, Mr. Garson has been in his
Secretary and General Counsel, current position since May
Loews Corporation 2003. Prior to that time he
was Vice President, Assistant
Secretary and Deputy General
Counsel of Loews Corporation.

Walter L. Harris President and Chief Executive Mr. Harris has been in his
Tanenbaum-Harber Co., Inc. Officer, Tanenbaum-Harber current position for more than
320 W. 57th Street Company, Inc. the past five years.
New York, NY 10019 (Loews Director)

Herbert C. Hofmann President and Chief Executive Mr. Hofmann has been in his
Bulova Corporation Officer, Bulova Corporation, current position for more than
One Bulova Avenue Senior Vice President, the past five years.
Woodside, NY 11377 Loews Corporation

Peter W. Keegan Senior Vice President and Mr. Keegan has been in his
Chief Financial Officer, current position for more than
Loews Corporation the past five years.

Philip A. Laskawy Retired Chairman and Mr. Laskawy retired from
Ernst & Young Chief Executive Officer, Ernst & Young in 2001.
5 Times Square Ernst & Young He was Chairman and Chief
New York, NY 10036 (Loews Director) Executive Officer of
Ernst & Young for more than
five years prior thereto.

Arthur L. Rebell Senior Vice President, Mr. Rebell has been in his
Loews Corporation current position for more than
the past five years.

Gloria R. Scott Owner, G. Randle Services Dr. Scott has been in her
539 South County Road 1142 (Loews Director) current position since 2001.
Riviera, TX 78379 Prior to that time Dr. Scott
was President of Bennett
College.

Andrew H. Tisch Chairman of the Executive Mr. Tisch has been in his
Committee and Member of the current position for more
Office of the President, than the past five years.
Loews Corporation
(Loews Director)

James S. Tisch President and Chief Executive Mr. Tisch has been in his
Officer and Member of the current position for more
Office of the President, than the past five years.
Loews Corporation
(Loews Director)

Jonathan M. Tisch Chairman and Chief Executive Mr. Tisch has been in his
Officer, Loews Hotels, and current position for more
Member of the Office of the than the past five years.
President, Loews Corporation
(Loews Director)

Preston R. Tisch Chairman of the Board, Mr. Tisch has been in his
Loews Corporation current position for more
(Loews Director) than the past five years.

26
1
379656.02-Wilmington Server 1A MSW - Draft April 28, 2004 - 10:15 PM

                                                                   Exhibit (a)

                                                                         [Date]


Dear Bulova Shareholder:

  Loews Corporation owns approximately 97% of the stock of Bulova Corporation,
which it has held for many years. The remaining 3% is owned by members of the
public, including you. In recent years it has become increasingly expensive
and complex to manage a company that has public shareholders. In light of
these concerns, and considering the very limited public ownership and trading
of Bulova's shares, Loews has decided to acquire all of the Bulova stock that
we do not already own for a price of $35 per share, which we will pay you in
cash.

  We will accomplish this by means of a "short form" merger, which we can do
without any approval or other action by Bulova's public shareholders or its
Board of Directors.  As a result of the merger, Loews will own 100% of Bulova
and you and Bulova's other public shareholders will be paid cash for their
shares. We expect to complete the merger in approximately three weeks and to
pay you for your shares shortly thereafter.

  Included with this letter is our Statement on Schedule 13E-3, which we have
filed with the Securities and Exchange Commission. The Schedule 13E-3 gives
detailed information about this transaction, including how it affects you, our
reasons for doing it, our views as to the fairness of the $35 per share price,
and your rights if you believe the price is unfairly low. Please read this
document carefully.

  If you believe that the $35 per share price is unfairly low, you will have
the right to have a court in New York determine the value of your Bulova
shares -- this is called an appraisal right -- and be paid the appraised value
determined by the court, which could be more or less than $35 per share. The
procedures to exercise this right are described in the enclosed document and
need to be followed carefully, so we recommend that you consult a lawyer if
you consider taking this step. You do not need to do anything else at this
time.

  After the merger is completed, we will mail you instructions on how to
surrender your Bulova shares for payment or, if you so choose, to exercise
your appraisal rights. You should not deliver your Bulova stock certificate(s)
to us or otherwise respond to this notice until after you have received those
instructions.

  If you have questions about this process, you should contact the Investor
Relations Department of Registrar and Transfer Company, Bulova's transfer
agent and the exchange and paying agent for this transaction, at 1-800-368-
5948 or by email at info@rtco.com.
                    -------------

                                             Very truly yours,

                                             Loews Corporation
2
381525.01-Wilmington Server 1A		MSW - Draft May 20, 2004 - 11:58 AM

                                                                   Exhibit (f)

Sections 623 and 910 of the New York Business Corporation Law

Section 623.  Procedure to enforce shareholder's right to receive payment for
shares

(a) A shareholder intending to enforce his right under a section of this
chapter to receive payment for his shares if the proposed corporate action
referred to therein is taken shall file with the corporation, before the
meeting of shareholders at which the action is submitted to a vote, or at such
meeting but before the vote, written objection to the action. The objection
shall include a notice of his election to dissent, his name and residence
address, the number and classes of shares as to which he dissents and a demand
for payment of the fair value of his shares if the action is taken. Such
objection is not required from any shareholder to whom the corporation did not
give notice of such meeting in accordance with this chapter or where the
proposed action is authorized by written consent of shareholders without a
meeting.

(b) Within ten days after the shareholders' authorization date, which term as
used in this section means the date on which the shareholders' vote
authorizing such action was taken, or the date on which such consent without a
meeting was obtained from the requisite shareholders, the corporation shall
give written notice of such authorization or consent by registered mail to
each shareholder who filed written objection or from whom written objection
was not required, excepting any shareholder who voted for or consented in
writing to the proposed action and who thereby is deemed to have elected not
to enforce his right to receive payment for his shares.

(c) Within twenty days after the giving of notice to him, any shareholder from
whom written objection was not required and who elects to dissent shall file
with the corporation a written notice of such election, stating his name and
residence address, the number and classes of shares as to which he dissents
and a demand for payment of the fair value of his shares. Any shareholder who
elects to dissent from a merger under section 905 (Merger of subsidiary
corporation) or paragraph (c) of section 907 (Merger or consolidation of
domestic and foreign corporations) or from a share exchange under paragraph
(g) of section 913 (Share exchanges) shall file a written notice of such
election to dissent within twenty days after the giving to him of a copy of
the plan of merger or exchange or an outline of the material features thereof
under section 905 or 913.

(d) A shareholder may not dissent as to less than all of the shares, as to
which he has a right to dissent, held by him of record, that he owns
beneficially. A nominee or fiduciary may not dissent on behalf of any
beneficial owner as to less than all of the shares of such owner, as to which
such nominee or fiduciary has a right to dissent, held of record by such
nominee or fiduciary.

  (e) Upon consummation of the corporate action, the shareholder shall cease
to have any of the rights of a shareholder except the right to be paid the
fair value of his shares and any other rights under this section. A notice of
election may be withdrawn by the shareholder at any time prior to his
acceptance in writing of an offer made by the corporation, as provided in
paragraph (g), but in no case later than sixty days from the date of
consummation of the corporate action except that if the corporation fails to
make a timely offer, as provided in paragraph (g), the time for withdrawing a
notice of election shall be extended until sixty days from the date an offer
is made. Upon expiration of such time, withdrawal of a notice of election
shall require the written consent of the corporation. In order to be
effective, withdrawal of a notice of election must be accompanied by the
return to the corporation of any advance payment made to the shareholder as
provided in paragraph (g). If a notice of election is withdrawn, or the
corporate action is rescinded, or a court shall determine that the shareholder
is not entitled to receive payment for his shares, or the shareholder shall
otherwise lose his dissenters' rights, he shall not have the right to receive
payment for his shares and he shall be reinstated to all his rights as a
shareholder as of the consummation of the corporate action, including any
intervening preemptive rights and the right to payment of any intervening
dividend or other distribution or, if any such rights have expired or any such
dividend or distribution other than in cash has been completed, in lieu
thereof, at the election of the corporation, the fair value thereof in cash as
determined by the board as of the time of such expiration or completion, but
without prejudice otherwise to any corporate proceedings that may have been
taken in the interim.

  (f) At the time of filing the notice of election to dissent or within one
month thereafter the shareholder of shares represented by certificates shall
submit the certificates representing his shares to the corporation, or to its
transfer agent, which shall forthwith note conspicuously thereon that a notice
of election has been filed and shall return the certificates to the
shareholder or other person who submitted them on his behalf. Any shareholder
of shares represented by certificates who fails to submit his certificates for
such notation as herein specified shall, at the option of the corporation
exercised by written notice to him within forty-five days from the date of
filing of such notice of election to dissent, lose his dissenter's rights
unless a court, for good cause shown, shall otherwise direct. Upon transfer of
a certificate bearing such notation, each new certificate issued therefor
shall bear a similar notation together with the name of the original
dissenting holder of the shares and a transferee shall acquire no rights in
the corporation except those which the original dissenting shareholder had at
the time of transfer.

  (g) Within fifteen days after the expiration of the period within which
shareholders may file their notices of election to dissent, or within fifteen
days after the proposed corporate action is consummated, whichever is later
(but in no case later than ninety days from the shareholders' authorization
date), the corporation or, in the case of a merger or consolidation, the
surviving or new corporation, shall make a written offer by registered mail to
each shareholder who has filed such notice of election to pay for his shares
at a specified price which the corporation considers to be their fair value.
Such offer shall be accompanied by a statement setting forth the aggregate
number of shares with respect to which notices of election to dissent have
been received and the aggregate number of holders of such shares. If the
corporate action has been consummated, such offer shall also be accompanied by
(1) advance payment to each such shareholder who has submitted the
certificates representing his shares to the corporation, as provided in
paragraph (f), of an amount equal to eighty percent of the amount of such
offer, or (2) as to each shareholder who has not yet submitted his
certificates a statement that advance payment to him of an amount equal to
eighty percent of the amount of such offer will be made by the corporation
promptly upon submission of his certificates. If the corporate action has not
been consummated at the time of the making of the offer, such advance payment
or statement as to advance payment shall be sent to each shareholder entitled
thereto forthwith upon consummation of the corporate action. Every advance
payment or statement as to advance payment shall include advice to the
shareholder to the effect that acceptance of such payment does not constitute
a waiver of any dissenters' rights. If the corporate action has not been
consummated upon the expiration of the ninety day period after the
shareholders' authorization date, the offer may be conditioned upon the
consummation of such action. Such offer shall be made at the same price per
share to all dissenting shareholders of the same class, or if divided into
series, of the same series and shall be accompanied by a balance sheet of the
corporation whose shares the dissenting shareholder holds as of the latest
available date, which shall not be earlier than twelve months before the
making of such offer, and a profit and loss statement or statements for not
less than a twelve month period ended on the date of such balance sheet or, if
the corporation was not in existence throughout such twelve month period, for
the portion thereof during which it was in existence. Notwithstanding the
foregoing, the corporation shall not be required to furnish a balance sheet or
profit and loss statement or statements to any shareholder to whom such
balance sheet or profit and loss statement or statements were previously
furnished, nor if in connection with obtaining the shareholders' authorization
for or consent to the proposed corporate action the shareholders were
furnished with a proxy or information statement, which included financial
statements, pursuant to Regulation 14A or Regulation 14C of the United States
Securities and Exchange Commission. If within thirty days after the making of
such offer, the corporation making the offer and any shareholder agree upon
the price to be paid for his shares, payment therefor shall be made within
sixty days after the making of such offer or the consummation of the proposed
corporate action, whichever is later, upon the surrender of the certificates
for any such shares represented by certificates.

(h) The following procedure shall apply if the corporation fails to make such
offer within such period of fifteen days, or if it makes the offer and any
dissenting shareholder or shareholders fail to agree with it within the period
of thirty days thereafter upon the price to be paid for their shares:

(1) The corporation shall, within twenty days after the expiration of
whichever is applicable of the two periods last mentioned, institute a special
proceeding in the supreme court in the judicial district in which the office
of the corporation is located to determine the rights of dissenting
shareholders and to fix the fair value of their shares. If, in the case of
merger or consolidation, the surviving or new corporation is a foreign
corporation without an office in this state, such proceeding shall be brought
in the county where the office of the domestic corporation, whose shares are
to be valued, was located.

(2) If the corporation fails to institute such proceeding within such period
of twenty days, any dissenting shareholder may institute such proceeding for
the same purpose not later than thirty days after the expiration of such
twenty day period. If such proceeding is not instituted within such thirty day
period, all dissenter's rights shall be lost unless the supreme court, for
good cause shown, shall otherwise direct.

(3) All dissenting shareholders, excepting those who, as provided in paragraph
(g), have agreed with the corporation upon the price to be paid for their
shares, shall be made parties to such proceeding, which shall have the effect
of an action quasi in rem against their shares. The corporation shall serve a
copy of the petition in such proceeding upon each dissenting shareholder who
is a resident of this state in the manner provided by law for the service of a
summons, and upon each nonresident dissenting shareholder either by registered
mail and publication, or in such other manner as is permitted by law. The
jurisdiction of the court shall be plenary and exclusive.

(4) The court shall determine whether each dissenting shareholder, as to whom
the corporation requests the court to make such determination, is entitled to
receive payment for his shares. If the corporation does not request any such
determination or if the court finds that any dissenting shareholder is so
entitled, it shall proceed to fix the value of the shares, which, for the
purposes of this section, shall be the fair value as of the close of business
on the day prior to the shareholders' authorization date. In fixing the fair
value of the shares, the court shall consider the nature of the transaction
giving rise to the shareholder's right to receive payment for shares and its
effects on the corporation and its shareholders, the concepts and methods then
customary in the relevant securities and financial markets for determining
fair value of shares of a corporation engaging in a similar transaction under
comparable circumstances and all other relevant factors. The court shall
determine the fair value of the shares without a jury and without referral to
an appraiser or referee. Upon application by the corporation or by any
shareholder who is a party to the proceeding, the court may, in its
discretion, permit pretrial disclosure, including, but not limited to,
disclosure of any expert's reports relating to the fair value of the shares
whether or not intended for use at the trial in the proceeding and
notwithstanding subdivision (d) of section 3101 of the civil practice law and
rules.

(5) The final order in the proceeding shall be entered against the corporation
in favor of each dissenting shareholder who is a party to the proceeding and
is entitled thereto for the value of his shares so determined.

(6) The final order shall include an allowance for interest at such rate as
the court finds to be equitable, from the date the corporate action was
consummated to the date of payment. In determining the rate of interest, the
court shall consider all relevant factors, including the rate of interest
which the corporation would have had to pay to borrow money during the
pendency of the proceeding. If the court finds that the refusal of any
shareholder to accept the corporate offer of payment for his shares was
arbitrary, vexatious or otherwise not in good faith, no interest shall be
allowed to him.

(7) Each party to such proceeding shall bear its own costs and expenses,
including the fees and expenses of its counsel and of any experts employed by
it. Notwithstanding the foregoing, the court may, in its discretion, apportion
and assess all or any part of the costs, expenses and fees incurred by the
corporation against any or all of the dissenting shareholders who are parties
to the proceeding, including any who have withdrawn their notices of election
as provided in paragraph (e), if the court finds that their refusal to accept
the corporate offer was arbitrary, vexatious or otherwise not in good faith.
The court may, in its discretion, apportion and assess all or any part of the
costs, expenses and fees incurred by any or all of the dissenting shareholders
who are parties to the proceeding against the corporation if the court finds
any of the following: (A) that the fair value of the shares as determined
materially exceeds the amount which the corporation offered to pay; (B) that
no offer or required advance payment was made by the corporation; (C) that the
corporation failed to institute the special proceeding within the period
specified therefor; or (D) that the action of the corporation in complying
with its obligations as provided in this section was arbitrary, vexatious or
otherwise not in good faith. In making any determination as provided in clause
(A), the court may consider the dollar amount or the percentage, or both, by
which the fair value of the shares as determined exceeds the corporate offer.

(8) Within sixty days after final determination of the proceeding, the
corporation shall pay to each dissenting shareholder the amount found to be
due him, upon surrender of the certificates for any such shares represented by
certificates.

(i) Shares acquired by the corporation upon the payment of the agreed value
therefor or of the amount due under the final order, as provided in this
section, shall become treasury shares or be cancelled as provided in section
515 (Reacquired shares), except that, in the case of a merger or
consolidation, they may be held and disposed of as the plan of merger or
consolidation may otherwise provide.

(j) No payment shall be made to a dissenting shareholder under this section at
a time when the corporation is insolvent or when such payment would make it
insolvent. In such event, the dissenting shareholder shall, at his option:

(1) Withdraw his notice of election, which shall in such event be deemed
withdrawn with the written consent of the corporation; or

(2) Retain his status as a claimant against the corporation and, if it is
liquidated, be subordinated to the rights of creditors of the corporation, but
have rights superior to the non-dissenting shareholders, and if it is not
liquidated, retain his right to be paid for his shares, which right the
corporation shall be obliged to satisfy when the restrictions of this
paragraph do not apply.

(3) The dissenting shareholder shall exercise such option under subparagraph
(1) or (2) by written notice filed with the corporation within thirty days
after the corporation has given him written notice that payment for his shares
cannot be made because of the restrictions of this paragraph. If the
dissenting shareholder fails to exercise such option as provided, the
corporation shall exercise the option by written notice given to him within
twenty days after the expiration of such period of thirty days.

(k) The enforcement by a shareholder of his right to receive payment for his
shares in the manner provided herein shall exclude the enforcement by such
shareholder of any other right to which he might otherwise be entitled by
virtue of share ownership, except as provided in paragraph (e), and except
that this section shall not exclude the right of such shareholder to bring or
maintain an appropriate action to obtain relief on the ground that such
corporate action will be or is unlawful or fraudulent as to him.

(l) Except as otherwise expressly provided in this section, any notice to be
given by a corporation to a shareholder under this section shall be given in
the manner provided in section 605 (Notice of meetings of shareholders).

(m) This section shall not apply to foreign corporations except as provided in
subparagraph (e)(2) of section 907 (Merger or consolidation of domestic and
foreign corporations).



Section 910. Right of shareholder to receive payment for shares upon merger or
consolidation, or sale, lease, exchange or other disposition of assets, or
share exchange

(a) A shareholder of a domestic corporation shall, subject to and by complying
with section 623 (Procedure to enforce shareholder's right to receive payment
for shares), have the right to receive payment of the fair value of his shares
and the other rights and benefits provided by such section, in the following
cases:

(1) Any shareholder entitled to vote who does not assent to the taking of an
action specified in clauses (A), (B) and (C).
(A) Any plan of merger or consolidation to which the corporation is a party;
except that the right to receive payment of the fair value of his shares shall
not be available:
(i) To a shareholder of the parent corporation in a merger authorized by
section 905 (Merger of parent and subsidiary corporations), or paragraph (c)
of section 907 (Merger or consolidation of domestic and foreign corporations);
or
(ii) To a shareholder of the surviving corporation in a merger authorized by
this article, other than a merger specified in subclause (i), unless such
merger effects one or more of the changes specified in subparagraph (b) (6) of
section 806 (Provisions as to certain proceedings) in the rights of the shares
held by such shareholder; or
(iii) Notwithstanding subclause (ii) of this clause, to a shareholder for the
shares of any class or series of stock, which shares or depository receipts in
respect thereof, at the record date fixed to determine the shareholders
entitled to receive notice of the meeting of shareholders to vote upon the
plan of merger or consolidation, were listed on a national securities exchange
or designated as a national market system security on an interdealer quotation
system by the National Association of Securities Dealers, Inc.
(B) Any sale, lease, exchange or other disposition of all or substantially all
of the assets of a corporation which requires shareholder approval under
section 909 (Sale, lease, exchange or other disposition of assets) other than
a transaction wholly for cash where the shareholders' approval thereof is
conditioned upon the dissolution of the corporation and the distribution of
substantially all of its net assets to the shareholders in accordance with
their respective interests within one year after the date of such transaction.
(C) Any share exchange authorized by section 913 in which the corporation is
participating as a subject corporation; except that the right to receive
payment of the fair value of his shares shall not be available to a
shareholder whose shares have not been acquired in the exchange or to a
shareholder for the shares of any class or series of stock, which shares or
depository receipt in respect thereof, at the record date fixed to determine
the shareholders entitled to receive notice of the meeting of shareholders to
vote upon the plan of exchange, were listed on a national securities exchange
or designated as a national market system security on an interdealer quotation
system by the National Association of Securities Dealers, Inc.

(2) Any shareholder of the subsidiary corporation in a merger authorized by
section 905 or paragraph (c) of section 907, or in a share exchange authorized
by paragraph (g) of section 913, who files with the corporation a written
notice of election to dissent as provided in paragraph (c) of section 623.

(3) Any shareholder, not entitled to vote with respect to a plan of merger or
consolidation to which the corporation is a party, whose shares will be
cancelled or exchanged in the merger or consolidation for cash or other
consideration other than shares of the surviving or consolidated corporation
or another corporation.